Protagonist Therapeutics Inc (PTGX)
46.23
-1.38
(-2.90%)
USD |
NASDAQ |
Nov 08, 16:00
46.23
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| June 30, 2022 | 45.48M |
| March 31, 2022 | 46.89M |
| December 31, 2021 | 27.36M |
| September 30, 2021 | 24.39M |
| June 30, 2021 | 27.22M |
| March 31, 2021 | 31.17M |
| December 31, 2020 | 28.63M |
| September 30, 2020 | 25.70M |
| June 30, 2020 | 16.72M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.318M |
| December 31, 2019 | 0.231M |
| September 30, 2019 | -0.135M |
| June 30, 2019 | 1.841M |
| March 31, 2019 | 21.70M |
| December 31, 2018 | 30.92M |
| September 30, 2018 | 39.85M |
| June 30, 2018 | 42.52M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.231M
Minimum
Dec 2019
46.89M
Maximum
Mar 2022
25.10M
Average
27.22M
Median
Jun 2021
Revenue (TTM) Benchmarks
| Johnson & Johnson | 87.70B |
| Assembly Biosciences Inc | -- |
| Precision BioSciences Inc | 75.10M |
| Entrada Therapeutics Inc | 215.23M |
| NovaBay Pharmaceuticals Inc | 12.02M |